ATE181924T1 - Modifizierter wachstumsfaktor der milch - Google Patents

Modifizierter wachstumsfaktor der milch

Info

Publication number
ATE181924T1
ATE181924T1 AT95916503T AT95916503T ATE181924T1 AT E181924 T1 ATE181924 T1 AT E181924T1 AT 95916503 T AT95916503 T AT 95916503T AT 95916503 T AT95916503 T AT 95916503T AT E181924 T1 ATE181924 T1 AT E181924T1
Authority
AT
Austria
Prior art keywords
growth factors
milk
modified
milk growth
product extract
Prior art date
Application number
AT95916503T
Other languages
English (en)
Inventor
David Andrew Belford
Mary-Louise Rogers
Geoffrey Leonard Francis
Geoffrey Owen Regester
Geoffrey Welsford Smithers
Francis John Ballard
Original Assignee
Gropep Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3779922&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE181924(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gropep Pty Ltd filed Critical Gropep Pty Ltd
Application granted granted Critical
Publication of ATE181924T1 publication Critical patent/ATE181924T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/205Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey from whey, e.g. lactalbumine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/70Undefined extracts
    • C12N2500/80Undefined extracts from animals
    • C12N2500/84Undefined extracts from animals from mammals

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT95916503T 1994-04-28 1995-04-26 Modifizierter wachstumsfaktor der milch ATE181924T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPM5347A AUPM534794A0 (en) 1994-04-28 1994-04-28 Modified milk growth factor

Publications (1)

Publication Number Publication Date
ATE181924T1 true ATE181924T1 (de) 1999-07-15

Family

ID=3779922

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95916503T ATE181924T1 (de) 1994-04-28 1995-04-26 Modifizierter wachstumsfaktor der milch

Country Status (9)

Country Link
US (1) US6194208B1 (de)
EP (1) EP0759029B1 (de)
JP (1) JP3640965B2 (de)
AT (1) ATE181924T1 (de)
AU (1) AUPM534794A0 (de)
CA (1) CA2188654C (de)
DE (1) DE69510669T2 (de)
NZ (2) NZ284389A (de)
WO (1) WO1995029933A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN271295A0 (en) * 1995-05-02 1995-05-25 Gropep Pty Ltd Method of treatment
EP0894094B1 (de) * 1996-03-15 2005-05-11 BioEqual AG Verfahren zur gewinnung eines komplexes aus wachstumsfaktoren
US5772999A (en) * 1996-07-30 1998-06-30 Dcv Biologics, L.P. Method of preventing, countering, or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals
GB9619660D0 (en) * 1996-09-20 1996-11-06 Scient Hospital Suppl Int Ltd Prevention of gastrointestinal damage
NL1005677C2 (nl) * 1997-03-27 1998-09-29 Campina Melkunie Bv Werkwijze voor het winnen van groeifactoren, of een samenstelling die één of meer groeifactoren bevat, uit melk of een derivaat daarvan.
ES2139525B1 (es) * 1997-11-17 2000-10-16 Sanchez Pedro Cuevas Empleo de derivados del lactosuero como citoprotectores y cicatrizantes.
AUPQ878600A0 (en) * 2000-07-13 2000-08-03 Gropep Pty Ltd Compositions and methods for the treatment of intact skin
MXPA04002387A (es) * 2001-09-12 2004-11-22 Eastern Virginia Med School Factor inhibidor de afluencia de calcio y metodo de aislamiento del mismo.
GB0209384D0 (en) 2002-04-24 2002-06-05 Pepsyn Ltd Peptide composition
US20060240116A1 (en) * 2005-04-22 2006-10-26 David Jolley Bioactive factors in wound healing topical compositions and methods
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
JP5662147B2 (ja) * 2007-08-15 2015-01-28 サンバイオ,インコーポレイティド 神経変性を治療するための方法及び組成物
US8367354B2 (en) * 2008-10-24 2013-02-05 Mead Johnson Nutrition Company Methods for determining the levels of TGF-β in a composition
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US8350006B2 (en) * 2008-10-24 2013-01-08 Mead Johnson Nutrition Company Methods for determining the bioactivity of TGF-β in a composition
AU2013204850B2 (en) * 2012-10-08 2015-06-25 Murray Goulburn Co-Operative Co. Limited Improved process for purifying milk proteins and products thereof
KR102576778B1 (ko) * 2020-01-09 2023-09-12 세종대학교산학협력단 세포 배양용 소태아혈청 대체 소재
EP4426333A1 (de) 2021-11-05 2024-09-11 FrieslandCampina Nederland B.V. Verwendung von tgf zur vorbeugung von virusinfektionen der atemwege
JP7711221B2 (ja) * 2021-12-28 2025-07-22 日本ハム株式会社 筋組織由来細胞の分化の抑制剤
JP7760610B2 (ja) * 2021-12-28 2025-10-27 日本ハム株式会社 培養肉製造のための細胞増殖用の培地

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440860A (en) 1980-01-18 1984-04-03 The Children's Medical Center Corporation Stimulating cell growth
IE54979B1 (en) * 1982-07-09 1990-04-11 Bridel Laiteries Process for treating milk with a cation-exchange resin for the preparation of decationised,acidified milk
ATE81779T1 (de) 1985-08-22 1992-11-15 Gropep Pty Ltd Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren.
US5221734A (en) * 1987-10-01 1993-06-22 Ciba-Geigy Corporation Process for preparing a polypeptide growth factor for milk
GB8723094D0 (en) 1987-10-01 1987-11-04 Ciba Geigy Ag Polypeptide growth factor from milk
DK513589A (da) 1988-10-20 1990-04-21 Smithkline Beecham Corp Human epitelcelleomdannende vaekstfaktor og fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende vaekstfaktoren
JPH03236772A (ja) * 1990-02-13 1991-10-22 Snow Brand Milk Prod Co Ltd 新規な細胞増殖促進物質及びこれを有効成分とする細胞培養培地添加物
FR2663816B1 (fr) * 1990-06-28 1993-08-06 Clar Procede de traitement du colostrum par chromatographie d'adsorption sur hydroxyapatite, fraction active de colostrum obtenue et milieu cellulaire contenant ladite fraction active.
DK0545946T3 (da) * 1990-07-13 2005-05-23 Gropep Ltd Vækstfremmende middel
EP0527283B1 (de) * 1991-08-12 1997-11-26 Societe Des Produits Nestle S.A. Nahrungsmittelzusammensetzung
FI91166C (fi) * 1991-10-17 1994-05-25 Valio Biotuotteet Oy Ternimaitofraktio, menetelmä sen valmistamiseksi ja sen käyttö kasvualustojen täydennysaineena
US5281582A (en) * 1992-02-27 1994-01-25 Alliance Pharmaceuticals, Corp. Serum growth factor
WO1993020713A1 (en) 1992-04-22 1993-10-28 Bopa Ireland Limited Products derived from whey and their use in foodstuffs
NL1005677C2 (nl) 1997-03-27 1998-09-29 Campina Melkunie Bv Werkwijze voor het winnen van groeifactoren, of een samenstelling die één of meer groeifactoren bevat, uit melk of een derivaat daarvan.

Also Published As

Publication number Publication date
DE69510669T2 (de) 1999-10-28
CA2188654C (en) 2007-04-24
DE69510669D1 (de) 1999-08-12
AUPM534794A0 (en) 1994-05-19
NZ284389A (en) 1997-04-24
JPH09512536A (ja) 1997-12-16
WO1995029933A1 (en) 1995-11-09
EP0759029A1 (de) 1997-02-26
JP3640965B2 (ja) 2005-04-20
EP0759029B1 (de) 1999-07-07
CA2188654A1 (en) 1995-11-09
EP0759029A4 (de) 1997-06-04
NZ314284A (en) 2000-06-23
US6194208B1 (en) 2001-02-27

Similar Documents

Publication Publication Date Title
DE69510669D1 (de) Modifizierter wachstumsfaktor der milch
FR2499990B1 (fr) Procede de preparation de derives d'acides quinoleinecarboxyliques, nouveaux produits ainsi obtenus et leur utilisation comme agents antibacteriens
ES8802390A1 (es) Un procedimiento para extraer la substancia quimica activa de la planta del aloe a partir de hojas de esta planta
BG105588A (en) Anthranilic acide amides and the use thereof as medicaments
DE3772221D1 (de) Suessware und verfahren zur herstellung derselben.
ES8500932A1 (es) Procedimiento para la obtencion de acidos quinoloncarboxilicos
ATA290483A (de) Verwendung von neuen 2-pyridylalkyl-sulfinylbenzimidazolen zur herstellung von die magensaeuresekretion beeinflussenden pharmazeutischen praeparaten
DE3679128D1 (de) Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben.
DK578882A (da) Farmaceutisk aktive phenylcarboxylsyrederivater
HUT67436A (en) Process to prepare novel hydroxamic acid and n-hydroxyurea derivatives and pharmaceutical compn.s contg. them
CS38989A2 (en) Method of phenoxyacetamidoderivative production
IS4537A (is) Seyði úr hákarlabrjóski, aðferð við framleiðslu þess og notkun
DE59000270D1 (de) Verwendung von mindestens ein cytokin zur herstellung eines arzneimittels zur systemischen behandlung von praeneoplastischen laesionen.
IT1019291B (it) Procedimento per la produzione di compositioni di proteine vegetali purificate e concentrate e prodotto ottenuto
BR9408392A (pt) Derivados de ácidos arilacéticos e sua utilização como fungicidas
FR2317924A1 (fr) Procede de production de derives d'ortho-aminobutyrophenone, nouveaux produits ainsi obtenus et leur utilisation comme agents analgesiques et antipsychose
ES2012128A6 (es) Metodo de tratar plantas con acidos organicos que contienen azufre.
ATE67175T1 (de) Verfahren zur herstellung von 6-alkoxy-5trifluormethyl-1-naphthoesaeuren und 1-cyanonaphthalenzwischenprodukten.
ES8107299A1 (es) Un procedimiento para la preparacion de un producto de cul- tivo o un liquido de cultivo de la nueva cepa trichosporon kashiwayama
ATE231141T1 (de) (-)-enantiomere von cis-3,4-chromanderivaten zur vorbeugung oder behandlungvon oestrogenbezogenen krankheiten oder syndromen
MA20666A1 (fr) Esters nouveaux d'acides vinylcyclopropane-carboxyliques, leur procede de production et leur utilisation comme pesticides
FR2447927B1 (fr) Procede de preparation de polyphosphites aromatiques et nouveaux produits ainsi obtenus, employes comme anti-oxydants pour polymeres
DE3784308D1 (de) Verwendung von somatostatin zur herstellung eines arzneimittels fuer die behandlung von rheumatoider arthritis.
FR2405298A1 (fr) Nouvelles glycoproteines isolees d'escherichia coli, procede de preparation et application de medicaments
EP0137499A3 (de) Verfahren zur Gewinnung von beta-Elemonsäure und diese enthaltende pharmazeutische Zubereitungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties